Back to the search results

SLK-Kliniken Heilbronn GmbH - Klinikum am Gesundbrunnen

Am Gesundbrunnen 20-26
74078 Heilbronn

Phone: 07131-49-0
Mail: ed.nekinilk-kls@ofni ed.nekinilk-kls@ofni ed.nekinilk-kls@ofni

http://www.slk-kliniken.de/home/
  • Number of beds: 971
  • Number of specialist departments: 16
  • Number of inpatient cases: 50.116
  • Number of partial inpatient cases: 661
  • Number of outpatient cases: 171.763
  • Hospital owners: SLK-Kliniken Heilbronn GmbH
  • Type of provider: öffentlich
  • Academic teaching hospital
      • Universität Heidelberg
External comparative quality assurance
Further information
Bezeichnung
Teilnahme externe Qualitätssicherung yes
Bezeichnung
Teilnahme externe Qualitätssicherung yes
Bezeichnung
Teilnahme externe Qualitätssicherung yes
Diabetes mellitus Typ 1

Quantity performed 277
Exception? No exception
Quantity performed 44
Exception? No exception
Quantity performed 26
Exception? No exception
Overall result forecast presentation: yes
Quantity performed reporting year: 44
Quantity forecast year: 55
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 277
Quantity forecast year: 280
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 26
Quantity forecast year: 23
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
No. Explanation
CQ25 Measures for quality assurance in the performance of minimally invasive heart valve interventions pursuant to Article 136, para. 1, sentence 1, number 2 for hospitals licensed in accordance with Article 108 of the SGB V
CQ05 Measures for quality assurance in the care of pre-term and full-term neonates – Perinatal Centre LEVEL 1
CQ02 Quality assurance measures for the inpatient care of children and adolescents with haemato-oncological diseases
  • Clarifying chat completed: no
  • Clarifying chat not completed: no
  • No participation in clarifying chat: no
  • Notification of non-fulfilment of nursing care not made: yes

Full record of compliance maintained

Number of days shown 366
Days of non-performance 0
Number of minimum requirements not met 0
Specific minimum requirements
Minimum requirement Days of non-performance
Doctor on duty 0
Supervision by a medical specialist 0
Geriatric expertise 0
Operating room equipment 0
Post-operative physiotherapy 0
Independent organisational unit 0
Minimum requirements for process quality
Minimum requirement Days of non-performance
SOP: Surgical procedures 0
SOP: Perioperative Planning 0
SOP: Capacity to consent 0
Standard Operating Procedure for the Management of Anticoagulants 0
SOP: Ortho-geriatric Care 0
SOP: Physiotherapy Measures 0
SOP: Patient-centred blood management 0
Number Group
223 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
172 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
170 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

  • Is a protection concept in place? Yes
  • Measures
    • Prevention
    • Intervention
    • Review
Gemäß Teil A § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß Teil A § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.
  • Drug commission

Im Orbis hinterlegt

19.12.2023

Im Orbis sind die Prozessschritte festgelegt.

19.12.2023

  • Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
  • Zubereitung durch pharmazeutisches Personal
  • Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen
  • Zentrale Zytostatikazubereitung in der Apotheke und Zubereitung von Ernährungslösungen insbesondere für Frühgeborene.
  • Vorhandensein von elektronischen Systemen zur Entscheidungsunterstützung (z.B. Meona®, Rpdoc®, AIDKlinik®, ID Medics® bzw. ID Diacos® Pharma)
  • Orbis Medication in Verbindung mit MMI Pharmindex Pro
  • Fallbesprechungen
  • Maßnahmen zur Vermeidung von Arzneimittelverwechslung
  • Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
  • Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)
  • Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
  • Aushändigung von Patienteninformationen zur Umsetzung von Therapieempfehlungen
  • Aushändigung des Medikationsplans
  • bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten
The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of ​​application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.
AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.
Job
Explanation

Explanation

Explanation

Explanation

Explanation

Explanation

Explanation

Explanation

Explanation

Training in other healing professions
Comment

Generalistik und Vertiefungsrichtung Pädiatrie

Comment

Ausbildung in Kooperation mit der MTAE Esslingen

Comment

Ausbildungsintegriertes Studium in Kooperation mit evangel. Hochschule Ludwigsburg

Comment

Kooperationen mit Vulpius-Klinik Bad Rappenau, Krankenhaus Öhringen + Kooperation mit der Klinik Löwenstein

Comment

Der Begriff Entbindungspfleger wurde gestrichen, ausbildungsintegriertes Studium in Kooperation mit DHBW Stuttgart

Comment

klinischer Teil von gesamt 720 Std. pro auszubildende Person am Standort Gesundbrunnen in Kooperation mit Notfallsanitäterschulen DRK + ASB + Johanniter

Comment

Berufsbezeichnung lautet: Medizinische Technologin / Medizinischer Technologe für Radiologie, seit Oktober 2023 an der GA, Kooperationen mit dem Caritaskrankenhaus Bad Mergentheim und den RKH-Kliniken

Comment

Die Bezeichnung für die Ausbildung lautet Gesundheits- und Krankenpflegehelfer/Krankenpflegehelferin

Comment

Kooperationen mit Vulpius-Klinik Bad Rappenau, Krankenhaus Öhringen + Kooperation mit der Klinik Löwenstein

SLK- Kliniken Heilbronn GmbH Klinikum am Gesundbrunnen

Patientenfürsprecher

Am Gesundbrunnen 20-26
74078 Heilbronn

Phone: 07131 -49-20010
Mail: ed.nekinilk-kls@ofni

Danh Neumann

Sekretariat der Geschäftsführung

Am Gesundbrunnen 20-26
74078 Heilbronn

Phone: 07131 -49-40001
Mail: ed.nekinilk-kls@kcabdeef

Michael Beck

Qualitätsmanagement

Am Gesundbrunnen 20-26
74078 Heilbronn

Phone: 07131 -49-48605
Mail: ed.nekinilk-kls@kcabdeef

Uwe Herrmann

Leitung Qualitätsmanagement

Am Gesundbrunnen 20-26
74078 Heilbronn

Phone: 07131 -49-48601
Mail: ed.nekinilk-kls@nnamrreh.ewu

Drug commission

Christian Roth

Schwerbehindertenvertretung

Am Gesundbrunnen 20-26
74078 Heilbronn

Phone: 00497131 -49-44040
Mail: ed.nekinilk-kls@htoR.naitsirhC

Am Gesundbrunnen 20-26
74078 Heilbronn

Phone: 07131-49-0
Mail: ed.nekinilk-kls@ofni

Antje Hemmann

Pflegedirektorin

Am Gesundbrunnen 20-26
74078 Heilbronn

Phone: 07131 -49-48000
Mail: ed.nekinilk-kls@nnammeh.ejtna

Melanie Junge

Kaufmännische Direktorin

Am Gesundbrunnen 20-26
74078 Heilbronn

Phone: 07131 -49-40100
Mail: ed.nekinilk-kls@egnuj.einalem

Melanie Junge

Kaufmännische Direktorin

Am Gesundbrunnen 20-26
74078 Heilbronn

Phone: 07131 -49-40100
Mail: ed.nekinilk-kls@egnuj.einalem

Prof. Dr. med. Wolfgang Linhart

Ärztlicher Direktor

Am Gesundbrunnen 20-26
74078 Heilbronn

Phone: 07131 -49-32001
Mail: ed.nekinilk-kls@ocu

IK: 260810794

Location number: 772048000

AltersTraumaZentrum

Certified until: 05.2027

Brustkrebszentrum

Certified until: 05.2029

Chest Pain Unit

Certified until: 12.2027

Cochlea-Implantat versorgende Einrichtung

Certified until: 06.2026

Darmkrebszentrum

Certified until: 05.2029

Gynäkologisches Krebszentrum

Certified until: 05.2029

Hautkrebszentrum

Certified until: 04.2028

Kopf-Hals-Tumor-Zentrum

Certified until: 05.2029

Magenkrebszentrum

Certified until: 05.2029

MUKOzert

Certified until: 12.2026

Nierenkrebszentrum

Certified until: 05.2027

Onkologisches Zentrum

Certified until: 05.2029

Pankreaskrebszentrum

Certified until: 05.2029

Prostatakrebszentrum

Certified until: 05.2027

TraumaZentrum

Certified until: 10.2027

Zentrum für Hämatologische Neoplasien

Certified until: 05.2029

Hospital portrait for download